Roy Galvin

Insider Reports History

Location
C/O Haemonetics Corporation, 125 Summer Street, Boston, MA
Signature
/s/ Thomas V. Powers, attorney-in-fact for Mr. Galvin
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Roy Galvin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
HAEMONETICS CORP EVP, Chief Commercial Officer Common Stock 12.8K $641K $50.01 Oct 31, 2025 Direct
HAEMONETICS CORP EVP, Chief Commercial Officer Non-qualified Stock Option (Right to Buy) 12.3K May 16, 2025 Direct

Insider Reports Filed by Roy Galvin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
HAE HAEMONETICS CORP Oct 31, 2025 1 -$7.25K 4 Nov 3, 2025 EVP, Chief Commercial Officer
HAE HAEMONETICS CORP May 16, 2025 2 $0 4/A Jun 13, 2025 EVP, Chief Commercial Officer
HAE HAEMONETICS CORP May 15, 2025 2 -$32K 4 May 19, 2025 President, Global Plasma & BC
HAE HAEMONETICS CORP Nov 1, 2024 1 -$11.5K 4 Nov 5, 2024 President, Global Plasma & BC
HAE HAEMONETICS CORP May 17, 2024 2 $0 4 May 21, 2024 President, Global Plasma & BC
HAE HAEMONETICS CORP May 15, 2024 1 -$20.6K 4 May 17, 2024 President, Global Plasma & BC
HAE HAEMONETICS CORP Nov 1, 2023 1 -$13.8K 4 Nov 3, 2023 President, Global Plasma & BC
HAE HAEMONETICS CORP May 15, 2023 2 $0 4 May 17, 2023 President, Global Plasma & BC
HAE HAEMONETICS CORP Nov 1, 2022 2 $0 4 Nov 3, 2022 President, Global Plasma & BC
HAE HAEMONETICS CORP Oct 10, 2022 0 $0 3 Oct 17, 2022 President, Global Plasma & BC